UNIVERSITY OF SOUTHERN CALIFORNIA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Effects of Nicotine in Tobacco Smokers
Phase 1
Completed
- Conditions
- Smoking, TobaccoSmoking (Tobacco) Addiction
- Interventions
- Drug: Cigarette 1Drug: Cigarette 2Drug: Patch 1Drug: Patch 2
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 221
- Registration Number
- NCT03651869
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).
Terminated
- Conditions
- Multiple Sclerosis
- Interventions
- Other: Assessment of leukocyte function.
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 97
- Registration Number
- NCT03647722
- Locations
- 🇺🇸
University of Southern California, Department of Neurology, Los Angeles, California, United States
Patient Adherence to Acupuncture Treatment
Not Applicable
Completed
- Conditions
- Adherence, Patient
- Interventions
- Behavioral: Text messageBehavioral: Telephone call
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 121
- Registration Number
- NCT03645083
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Lactated Ringer's Versus Normal Saline for Acute Pancreatitis
Not Applicable
Completed
- Conditions
- Pancreatitis, Acute
- Interventions
- Other: Fluid administration
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 121
- Registration Number
- NCT03642769
- Locations
- 🇺🇸
LAC+USC Medical Center, Los Angeles, California, United States
Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery
Phase 4
Completed
- Conditions
- Postoperative PainShoulder Pain
- Interventions
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 40
- Registration Number
- NCT03638960
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Alzheimer Prevention Trials (APT) Webstudy
Recruiting
- Conditions
- Alzheimer DiseaseDementia
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 200000
- Registration Number
- NCT03638583
- Locations
- 🇺🇸
Https://Www.Aptwebstudy.Org, San Diego, California, United States
DHA Brain Delivery Trial
Phase 2
Completed
- Conditions
- Brain DHA Delivery and Alzheimer's Disease Risk
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 365
- Registration Number
- NCT03613844
- Locations
- 🇺🇸
USC Keck School of Medicine, Los Angeles, California, United States
Knowledge and Interpersonal Skills to Develop Exemplary Relationships
Not Applicable
Terminated
- Conditions
- CaregiversElder AbuseFamily RelationsDomestic Violence
- Interventions
- Behavioral: KINDER
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 23
- Registration Number
- NCT03593564
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients
Terminated
- Conditions
- Microsatellite InstabilityColorectal Cancer Stage IV
- Interventions
- Procedure: Specimen CollectionProcedure: Serial Liquid Biopsy
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 6
- Registration Number
- NCT03594448
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
Phase 1
Withdrawn
- Conditions
- Colorectal AdenocarcinomaRefractory Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8CpG Island Methylator PhenotypeMetastatic Microsatellite Stable Colorectal CarcinomaStage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8
- Interventions
- Biological: Nivolumab
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT03576963
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
© Copyright 2025. All Rights Reserved by MedPath